Allergan And Editas Sharpen Their CRISPR Focus On Ocular Drugs

 
• By Sten Stovall
  
SC1808_Genome Editing_1146082469_1200.jpg
Duo to jointly develop and market EDIT-101 For LCA10 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip